Establishment Labs Holdings (ESTA) Interest Expenses (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Interest Expenses came in at $19.6 million in Q1 2026, up 234.96% year-on-year from $5.9 million in Q1 2025, and up 590.56% quarter-over-quarter from $2.8 million in Q4 2025.
Establishment Labs Holdings (ESTA) Interest Expenses (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Interest Expenses history runs 10 years deep, the most recent figure standing at $19.6 million for Q1 2026.
- On a quarterly basis, Interest Expenses rose 234.96% year-over-year to $19.6 million in Q1 2026; TTM through Mar 2026 was $19.6 million, a 9.82% decrease from a year earlier, with the FY2025 full-year figure at $35.9 million, up 70.15% from the prior year.
- Interest Expenses rose to $19.6 million in Q1 2026 per ESTA's latest filing, from $2.8 million in the prior quarter.
- Across five years, Interest Expenses topped out at $19.6 million in Q1 2026 and bottomed at -$7.4 million in Q4 2022.
- The 5-year median for Interest Expenses is $4.4 million (2024), against an average of $5.6 million.
- Across the five-year window, Interest Expenses sank 416.42% in 2022 and jumped 272.55% in 2023, its largest moves.
- Year by year, Interest Expenses stood at -$7.4 million in 2022, then soared by 272.55% to $12.7 million in 2023, then sank by 63.09% to $4.7 million in 2024, then tumbled by 39.44% to $2.8 million in 2025, then jumped by 590.56% to $19.6 million in 2026.
- Per Business Quant, the three latest ESTA Interest Expenses figures stand at $19.6 million (Q1 2026), $2.8 million (Q4 2025), and $6.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.50 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 142.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 400.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -97.17 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -140.00 Mn |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | 19.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.61 Mn |
| Mar 31, 2026 | 19.61 Mn |
| Dec 31, 2025 | 2.84 Mn |
| Dec 31, 2025 | 2.84 Mn |
| Sep 30, 2025 | 6.20 Mn |
| Sep 30, 2025 | 6.20 Mn |
| Jun 30, 2025 | 13.88 Mn |
| Jun 30, 2025 | 13.88 Mn |
| Mar 31, 2025 | 5.85 Mn |
| Mar 31, 2025 | 5.85 Mn |
| Dec 31, 2024 | 4.69 Mn |
| Dec 31, 2024 | 4.69 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Jun 30, 2024 | 5.20 Mn |
| Jun 30, 2024 | 5.20 Mn |
| Mar 31, 2024 | 4.38 Mn |
| Mar 31, 2024 | 4.38 Mn |
| Dec 31, 2023 | 12.70 Mn |
| Dec 31, 2023 | 12.70 Mn |